PeterLabs Holdings Berhad (PLABS) Stock Overview
An investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products in Malaysia and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
PLABS Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
PeterLabs Holdings Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.25 |
| 52 Week High | RM 0.55 |
| 52 Week Low | RM 0.16 |
| Beta | 0.57 |
| 1 Month Change | 0% |
| 3 Month Change | -12.28% |
| 1 Year Change | 38.89% |
| 3 Year Change | 28.21% |
| 5 Year Change | 11.11% |
| Change since IPO | 4.17% |
Recent News & Updates
Recent updates
PeterLabs Holdings Berhad's (KLSE:PLABS) 53% Share Price Surge Not Quite Adding Up
May 16
We Think PeterLabs Holdings Berhad (KLSE:PLABS) Can Stay On Top Of Its Debt
Apr 18Is PeterLabs Holdings Berhad (KLSE:PLABS) Using Too Much Debt?
Dec 20PeterLabs Holdings Berhad (KLSE:PLABS) Seems To Use Debt Quite Sensibly
Nov 10Is PeterLabs Holdings Berhad (KLSE:PLABS) A Risky Investment?
Jan 28With EPS Growth And More, PeterLabs Holdings Berhad (KLSE:PLABS) Makes An Interesting Case
Nov 10Is Now The Time To Put PeterLabs Holdings Berhad (KLSE:PLABS) On Your Watchlist?
Feb 02
Are PeterLabs Holdings Berhad's (KLSE:PLABS) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Dec 28Are PeterLabs Holdings Berhad's (KLSE:PLABS) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 30Shareholder Returns
| PLABS | MY Pharmaceuticals | MY Market | |
|---|---|---|---|
| 7D | 2.0% | -0.2% | 0.5% |
| 1Y | 38.9% | -1.2% | 0.3% |
Return vs Industry: PLABS exceeded the MY Pharmaceuticals industry which returned -1.3% over the past year.
Return vs Market: PLABS exceeded the MY Market which returned -0.1% over the past year.
Price Volatility
| PLABS volatility | |
|---|---|
| PLABS Average Weekly Movement | 6.8% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in MY Market | 10.9% |
| 10% least volatile stocks in MY Market | 2.5% |
Stable Share Price: PLABS has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: PLABS's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Tong Lim | www.peterlabs.com.my |
PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products in Malaysia and internationally. The company operates through three segments: Manufacturing, Trading, and Others. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements.
PeterLabs Holdings Berhad Fundamentals Summary
| PLABS fundamental statistics | |
|---|---|
| Market cap | RM 68.80m |
| Earnings (TTM) | RM 1.52m |
| Revenue (TTM) | RM 161.47m |
Is PLABS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PLABS income statement (TTM) | |
|---|---|
| Revenue | RM 161.47m |
| Cost of Revenue | RM 141.96m |
| Gross Profit | RM 19.51m |
| Other Expenses | RM 17.99m |
| Earnings | RM 1.52m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0055 |
| Gross Margin | 12.08% |
| Net Profit Margin | 0.94% |
| Debt/Equity Ratio | 23.7% |
How did PLABS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/11 12:46 |
| End of Day Share Price | 2025/11/11 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PeterLabs Holdings Berhad is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yap Huey Chiang | RHB Investment Bank |